If you do decide to purchase the Medifocus Guidebook through the Medifocus link on this page, Medifocus will donate 30% of the sales proceeds to the EPDA.
The Parkinson's information leaflet series has been produced in collaboration with the European Parkinson's Disease Association (EPDA) and was supported by an unrestricted educational grant from Novartis Pharma AG and Orion Corporation, Orion Pharma.
Leaflet 1 of this series introduces the range of medications and surgical treatments available for the treatment of Parkinson's disease. If you have any questions about your Parkinson's disease treatment, you may want to discuss them with your doctor or other healthcare professional.
The Parkinson's information leaflet series has been produced in collaboration with the European Parkinson's Disease Association (EPDA) and was supported by an unrestricted educational grant from Novartis Pharma AG and Orion Corporation, Orion Pharma.
Leaflet 2 of this series discusses the specialist team available for the management of Parkinson's and the central role you and your family play in this team. There is also practical advice for everyday life with Parkinson's.
The Parkinson's information leaflet series has been produced in collaboration with the European Parkinson's Disease Association (EPDA) and was supported by an unrestricted educational grant from Novartis Pharma AG and Orion Corporation, Orion Pharma.
Managing your medication is the most important part of effectively controlling the symptoms of Parkinson's disease. It is also important to stay positive and keep up a healthy lifestyle by eating well and keeping active. This third leaflet of the Parkinson's leaflet information series has been prepared following interviews with people with Parkinson's, who provided their first-hand experience of what having the condition means to them, and includes their advice on adjusting to the changes Parkinson's makes to your life.
The Parkinson's information leaflet series has been produced in collaboration with the European Parkinson's Disease Association (EPDA) and was supported by an unrestricted educational grant from Novartis Pharma AG and Orion Corporation, Orion Pharma.
Leaflet 4 of this series looks at the long-term problem in Parkinson's of symptom re-emergence or 'wearing off'. In particular, how you can work with your doctor and other healthcare professionals to recognize and manage the signs and symptoms of wearing off.
The Parkinson's information leaflet series has been produced in collaboration with the European Parkinson's Disease Association (EPDA) and was supported by an unrestricted educational grant from Novartis Pharma AG and Orion Corporation, Orion Pharma.
Leaflet 5 aims to answer some of the more complicated questions about Parkinson's disease and its treatment, providing an insight into recent developments and research. This includes what researchers and clinicians think about Parkinson's today. If you have questions about the topics discussed in this leaflet, or if there is anything that you do not understand, you may want to discuss this further with your doctor or other healthcare professional.
The Parkinson's information leaflet series has been produced in collaboration with the European Parkinson's Disease Association (EPDA) and was supported by an unrestricted educational grant from Novartis Pharma AG and Orion Corporation, Orion Pharma.
Leaflet 6 discusses the central role you, as a caregiver, play in the care of somebody with Parkinson's disease. There is also practical advice on a variety of topics that might make taking on this responsibility easier, and remind you that your own health is also very important. For more information on Parkinson's you may find that it useful to read the other five leaflets in the full leaflet series.
